- Home
- RXT vs CVRX Comparison
RXT vs CVRX Comparison
Compare RXT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXT
- CVRX
- Stock Information
- Founded
- RXT 1998
- CVRX 2000
- Country
- RXT United States
- CVRX United States
- Employees
- RXT N/A
- CVRX N/A
- Industry
- RXT EDP Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RXT Technology
- CVRX Health Care
- Exchange
- RXT Nasdaq
- CVRX Nasdaq
- Market Cap
- RXT 501.7M
- CVRX 419.8M
- IPO Year
- RXT 2020
- CVRX 2021
- Fundamental
- Price
- RXT $1.69
- CVRX $12.45
- Analyst Decision
- RXT Sell
- CVRX Strong Buy
- Analyst Count
- RXT 2
- CVRX 7
- Target Price
- RXT $2.15
- CVRX $17.83
- AVG Volume (30 Days)
- RXT 1.0M
- CVRX 210.8K
- Earning Date
- RXT 05-08-2025
- CVRX 04-29-2025
- Dividend Yield
- RXT N/A
- CVRX N/A
- EPS Growth
- RXT N/A
- CVRX N/A
- EPS
- RXT N/A
- CVRX N/A
- Revenue
- RXT $2,737,100,000.00
- CVRX $51,292,000.00
- Revenue This Year
- RXT N/A
- CVRX $27.21
- Revenue Next Year
- RXT $1.73
- CVRX $25.87
- P/E Ratio
- RXT N/A
- CVRX N/A
- Revenue Growth
- RXT N/A
- CVRX 30.53
- 52 Week Low
- RXT $1.45
- CVRX $6.40
- 52 Week High
- RXT $3.41
- CVRX $19.24
- Technical
- Relative Strength Index (RSI)
- RXT 27.44
- CVRX 44.32
- Support Level
- RXT $1.56
- CVRX $11.80
- Resistance Level
- RXT $1.93
- CVRX $12.94
- Average True Range (ATR)
- RXT 0.12
- CVRX 0.56
- MACD
- RXT -0.01
- CVRX 0.17
- Stochastic Oscillator
- RXT 22.69
- CVRX 53.94
About RXT Rackspace Technology Inc.
Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.